Provided by Tiger Fintech (Singapore) Pte. Ltd.

TATA HEALTH

0.300
0.000
Volume:- -
Turnover:- -
Market Cap:72.90M
PE:-1.07
High:0.300
Open:0.300
Low:0.300
Close:0.300
52wk High:0.300
52wk Low:0.300
Shares:243.00M
HK Float Shares:242.85M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.281
ROE:-414.68%
ROA:-31.48%
PB:-1.49
PE(LYR):-1.07
PS:0.77

Loading ...

TATA Health (1255) Releases Internal Control Review Findings and Continues Trading Suspension

Bulletin Express
·
Nov 10

Tata Health International Reports Loss of Records and Loss of Subsidiary Control

Reuters
·
Nov 10

TATA Health (01255) Announces September 2025 Monthly Return

Bulletin Express
·
Nov 03

TATA Health International Holdings Limited (01255) Announces Monthly Return for October 2025

Bulletin Express
·
Nov 03

TATA Health Names CEO, CFO

MT Newswires Live
·
Oct 21

TATA Health (1255) Announces Board Composition and Committee Membership

Bulletin Express
·
Oct 21

TATA Health International (1255) Announces Director Re-designation, New CEO, and CFO Appointment

Bulletin Express
·
Oct 21

TATA HEALTH (01255): Zhang Mingqi Transitioned from Non-Executive Director to Executive Director

Stock News
·
Oct 21

Tata Health International Holdings Files Director List with HKEX

Reuters
·
Oct 21

BRIEF-Tata Health International Appoints Che Kean Tat As CFO

Reuters
·
Oct 21

TATA Health International Holdings Ltd - Zhang Ming Qi Appointed as Executive Director, CEO

THOMSON REUTERS
·
Oct 21

TATA Health International Holdings Ltd - Che Kean TAT Appointed as CFO of TATA Health

THOMSON REUTERS
·
Oct 21

Labor unions sue US over monitoring social media of visa holders

Reuters
·
Oct 17

TATA HEALTH (01255): Tan Kaiguo Appointed as Independent Non-Executive Director and Chairman of Audit Committee

Stock News
·
Sep 30

TATA Health International Swings to Profit in H1 Even as Revenue Falls 42%

MT Newswires Live
·
Sep 29

TATA HEALTH (01255) Reports 2024 Interim Results with Shareholder Loss of HK$5.13 Million, Narrowed by 58.38% Year-over-Year

Stock News
·
Sep 22

Tata Health Reports 30.5% Revenue Drop for H1 2024, Loss Narrows to HK$5.13 Million, EPS at HK$0.02

Reuters
·
Sep 22

TATA HEALTH (01255) Receives Additional Resumption Guidance from Hong Kong Stock Exchange

Stock News
·
Sep 15

Tata Health International Holdings Faces Continued Trading Suspension on Hong Kong Stock Exchange Amid Compliance Issues

Reuters
·
Sep 15

TATA HEALTH (01255) Reports 2023 Annual Results with HK$32.294 Million Loss Attributable to Owners, Turning from Profit to Loss Year-over-Year

Stock News
·
Sep 10